Inovio Pharmaceuticals
INO
#8890
Rank
A$0.21 B
Marketcap
A$3.19
Share price
-1.84%
Change (1 day)
-49.39%
Change (1 year)

Earnings for Inovio Pharmaceuticals (INO)

Earnings in 2025 (TTM): -A$0.17 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's current earnings are A$0.18 Million. In 2024 the company made an earning of -A$0.17 Billion, an increase over its 2023 earnings that were of -A$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inovio Pharmaceuticals from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.17 Billion4.17%
2024 -A$0.17 Billion-20.03%
2023 -A$0.21 Billion-51.56%
2022 -A$0.42 Billion-8.26%
2021 -A$0.46 Billion95.4%
2020 -A$0.24 Billion36.62%
2019 -A$0.17 Billion20.19%
2018 -A$0.15 Billion10.94%
2017 -A$0.13 Billion9.59%
2016 -A$0.12 Billion118.9%
2015 -A$52.92 Million-10.67%
2014 -A$59.24 Million83.32%
2013 -A$32.32 Million
2011 -A$33.34 Million15.64%
2010 -A$28.83 Million37.7%
2009 -A$20.94 Million2.19%
2008 -A$20.49 Million-14.09%
2007 -A$23.85 Million19.12%
2006 -A$20.02 Million9.62%
2005 -A$18.27 Million5.77%
2004 -A$17.27 Million73.08%
2003 -A$9.98 Million12.75%
2002 -A$8.85 Million
2000 -A$13.39 Million53.93%
1999 -A$8.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$17.77 B-11,064.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.58 B-30,070.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-A$0.12 Billion-30.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$24.62 B-15,289.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
A$34.63 B-21,461.43%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$13.98 B-8,724.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
A$14.82 B-9,245.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
-A$4.13 Million-97.45%๐Ÿ‡บ๐Ÿ‡ธ USA